ask="N/A"
ask_size="N/A"
average_daily_volume="125998"
bid="5.15"
bid_size="100"
book_value="3.76"
change="-0.02"
change_from_200_day_moving_average="0.01"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-4.53"
change_From_52_week_low="2.38"
change_in_percent="-0.25%"
close="7.97"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.82"
ebitda="-8.83M"
eps_estimate_current_year="-2.31"
eps_estimate_next_quarter="-0.55"
eps_estimate_next_year="-2.53"
ex_dividend_date="N/A"
float_shares="7622000"
high="8.11"
high_52_weeks="12.50"
last_trade_date="3/16/2017"
last_trade_price="7.97"
last_trade_size="281"
last_trade_time="4:00pm"
low="7.80"
low_52_weeks="5.59"
market_capitalization="151.77M"
moving_average_200_day="7.96"
moving_average_50_day="7.76"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.00"
open="8.05"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.09%"
percent_change_from_50_day_moving_average="+2.71%"
percent_change_from_52_week_high="-36.24%"
percent_change_from_52_week_low="+42.58%"
previous_close="7.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.12"
price_per_sales="2.19"
revenue="69.34M"
shares_outstanding="19043000"
short_ratio="5.77"
stock_exchange="NCM"
symbol="REPH"
volume="139730"
weeks_range_52="5.59 - 12.50"
